Elevation Oncology
Henry Koon serves as the Vice President of Clinical Development at Elevation Oncology since June 2024. Prior to this role, Henry Koon was a Senior Medical Director at BioNTech SE from October 2023 to July 2024, and worked at Bristol Myers Squibb from November 2017 to October 2023 as a Clinical Development Lead and Clinical Trial Lead. Previous experience includes positions at Seidman Cancer Center/Case Western Reserve Medical School from June 2007 to November 2017 as an Associate Professor and Director of the Medical Oncology Program in Cutaneous Malignancy, along with earlier roles at Beth Israel Deaconess Medical Center/Harvard Medical School from July 1997 to June 2007 as an Attending Physician in the Cutaneous Oncology Program. Henry Koon earned a B.S. in Pharmacy from the University of Mississippi in 1990 and an M.D. from the University of Mississippi School of Medicine from 1990 to 1994.
This person is not in the org chart
Elevation Oncology
Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. They make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease.